Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Radnor Capital Management LLC

Radnor Capital Management LLC cut its position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 12.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,109 shares of the company’s stock after selling 300 shares during the period. Radnor Capital Management LLC’s holdings in Cardinal Health were worth $249,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CAH. State Street Corp increased its position in Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after purchasing an additional 627,253 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after acquiring an additional 42,082 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after acquiring an additional 191,568 shares during the period. ProShare Advisors LLC lifted its holdings in shares of Cardinal Health by 5.1% during the 2nd quarter. ProShare Advisors LLC now owns 1,759,299 shares of the company’s stock valued at $172,974,000 after acquiring an additional 85,247 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the topic of several research reports. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Morgan Stanley boosted their price target on Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 17th. Wells Fargo & Company raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and increased their price objective for the company from $101.00 to $127.00 in a research report on Friday, December 13th. Barclays boosted their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Finally, Mizuho initiated coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target for the company. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $133.29.

Check Out Our Latest Analysis on CAH

Cardinal Health Stock Performance

Shares of CAH stock opened at $127.03 on Friday. The stock has a market capitalization of $30.74 billion, a price-to-earnings ratio of 24.71, a PEG ratio of 1.48 and a beta of 0.63. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $127.08. The company’s 50-day simple moving average is $120.46 and its 200-day simple moving average is $111.50.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. During the same quarter last year, the business posted $1.73 EPS. Cardinal Health’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s dividend payout ratio is presently 39.30%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.